Icosavax Analyst Ratings
Icosavax Analyst Ratings
While ratings are subjective and will change, the latest Icosavax (ICVX) rating was a reiterated with a price target of $0.00 to $25.00. The current price Icosavax (ICVX) is trading at is $7.75, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/02/2023 | 222.58% | Oppenheimer | → $25 | Reiterates | Outperform → Outperform |
| 04/25/2023 | 248.39% | Oppenheimer | → $27 | Reiterates | → Outperform |
| 01/04/2023 | 248.39% | Oppenheimer | → $27 | Initiates Coverage On | → Outperform |
| 08/23/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 08/23/2021 | 545.16% | Evercore ISI Group | → $50 | Initiates Coverage On | → Outperform |
| 08/23/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 08/23/2021 | 545.16% | Jefferies | → $50 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 10/02/2023 | 222.58% | 奥本海默 | →$25 | 重申 | 跑赢→跑赢大盘 |
| 04/25/2023 | 248.39% | 奥本海默 | →$27 | 重申 | →跑赢大盘 |
| 01/04/2023 | 248.39% | 奥本海默 | →$27 | 开始承保 | →跑赢大盘 |
| 2021/08/23 | - | 威廉·布莱尔 | 开始承保 | →跑赢大盘 | |
| 2021/08/23 | 545.16% | Evercore ISI集团 | →$50 | 开始承保 | →跑赢大盘 |
| 2021/08/23 | - | 考恩公司 | 开始承保 | →跑赢大盘 | |
| 2021/08/23 | 545.16% | 杰富瑞 | →$50 | 开始承保 | →购买 |
What is the target price for Icosavax (ICVX)?
ICosavax(ICVX)的目标价是多少？
The latest price target for Icosavax (NASDAQ: ICVX) was reported by Oppenheimer on October 2, 2023. The analyst firm set a price target for $25.00 expecting ICVX to rise to within 12 months (a possible 222.58% upside). 3 analyst firms have reported ratings in the last year.
奥本海默于2023年10月2日报道了ICosavax(纳斯达克代码：ICVX)的最新目标价。这家分析公司将目标价定为25美元，预计洲际交易所将在12个月内上涨(可能上涨222.58%)。3家分析公司在过去一年公布了评级。
What is the most recent analyst rating for Icosavax (ICVX)?
ICosavax(ICVX)的最新分析师评级是多少？
The latest analyst rating for Icosavax (NASDAQ: ICVX) was provided by Oppenheimer, and Icosavax reiterated their outperform rating.
纳斯达克(Sequoia Capital：ICVX)的最新分析师评级是由奥本海默提供的，该公司重申了其表现优于大盘的评级。
When is the next analyst rating going to be posted or updated for Icosavax (ICVX)?
ICosavax(ICVX)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Icosavax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Icosavax was filed on October 2, 2023 so you should expect the next rating to be made available sometime around October 2, 2024.
分析师在进行了广泛的研究后得出股票评级，其中包括查阅公开财务报表，与ICosavax的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。ICosavax的上一次评级是在2023年10月2日提交的，所以你应该预计下一次评级将在2024年10月2日左右的某个时候提供。
Is the Analyst Rating Icosavax (ICVX) correct?
分析师对ICosavax(ICVX)的评级正确吗？
While ratings are subjective and will change, the latest Icosavax (ICVX) rating was a reiterated with a price target of $0.00 to $25.00. The current price Icosavax (ICVX) is trading at is $7.75, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的ICosavax(ICVX)评级被重申，目标价在0.00美元至25.00美元之间。目前ICosavax(ICVX)的交易价格为7.75美元，在分析师的预测范围内。
